Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.008 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |